Objectives: In the current study, we examined whether infants at “High-Risk” for ASD because they have an older sibling diagnosed with the disorder, show an elevated predisposition for GI distress (possibly due to Leaky-Gut), and whether this predisposition is affected by choice of diet.
Methods: Our sample included 38 “High-Risk” infants (from families with an older sibling with ASD) and 83 “Low-Risk” control infants (from families with an older sibling, but no ASD history). Parents filled out extensive questionnaires about their infant’s GI history and diet, between the ages of 1- and 6-months. They were asked to report on the absence/presence of GI problems that were serious enough to seek medical advice, and at what age this occurred. They were also asked to report the infant’s diet history between 1- and 6-months, selecting one of three categories: breast-milk only (BMO), no breast-milk (NBM) and sometimes breast-milk (SBM).
Results: Across diet categories, the incidence of GI problems in High-Risk infants (47%) was 1.5-fold higher than in Low-Risk infants (33%). These effects varied with diet category. Whereas High- and Low-Risk infants exhibited about the same incidence of GI distress when fed a BMO diet (High-Risk = 25%, Low-Risk = 24%), when fed a NBM diet, GI problems in High-Risk infants (61.5%) were 2.9-fold higher (p = 0.034, chi-squared) than in Low-Risk infants (21.4%). These effects were not driven by age, i.e., they were not due to infants tending to be younger in the BMO, than in the NBM, category.
Conclusions: The impact of a non-breast milk diet on GI distress is greater in High-Risk, than Low-Risk infants, with High-Risk infants showing atypically elevated GI distress when not on a BMO diet. Such findings are consistent with the possibility that GI distress in association with ASD may result from an interaction between Leaky-Gut and diet early in development. We are tracking biological markers of Leaky-Gut in these infants, which will help elucidate the nature of their GI distress and hopefully lead to effective early intervention. Supported by NS071580.
See more of: Medical Co-Morbid Conditions
See more of: Symptoms, Diagnosis & Phenotype